Search
for

    Did you mean Myotonic Dystrophy Type 1?
    Glossary Myotonic Dystrophy Type 1

    genetic disorder causing progressive muscle wasting and weakness

    Myotonic Dystrophy Type 1 (DM1), also known as Steinert disease, is a genetic disorder characterized by progressive muscle wasting and weakness. It is caused by a mutation in the DMPK gene, leading to an abnormal expansion of DNA repeats that disrupts normal cellular function. Symptoms can include muscle stiffness (myotonia), cataracts, heart conduction defects, and endocrine changes, and the severity can vary widely among individuals.

    Related Terms

    Sort by

    Research

    30 / 1000+ results

      research Myotonic Dystrophy—A Progeroid Disease?

      41 citations , July 2018 in “Frontiers in Neurology”
      This study suggests that myotonic dystrophies may qualify as segmental progeroid disorders due to molecular and clinical similarities with typical progeroid syndromes.
      Three Cases of Androgen-Dependent Disease Associated with Myotonic Dystrophy

      research Three cases of androgen‐dependent disease associated with myotonic dystrophy

      8 citations , January 2003 in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”
      This study describes three female cases of androgen-dependent diseases in myotonic dystrophy, suggesting that peripheral androgen response, rather than serum levels, may drive such conditions.
      Skin Features in Myotonic Dystrophy Type 1: An Observational Study

      research Skin features in myotonic dystrophy type 1: An observational study

      8 citations , March 2015 in “Neuromuscular Disorders”
      This study found that adult patients with Myotonic Dystrophy type 1 exhibited a higher prevalence of various morphofunctional, inflammatory, and proliferative skin disorders compared to healthy controls.
      Late Presentation of Myotonic Dystrophy

      research Late presentation of myotonic dystrophy

      5 citations , January 1998 in “Clinical and experimental dermatology”
      This article discusses the late presentation of myotonic dystrophy but reports no new clinical findings.
      Cellular Senescence and Aging in Myotonic Dystrophy

      research Cellular Senescence and Aging in Myotonic Dystrophy

      4 citations , February 2022 in “International Journal of Molecular Sciences”
      This review discusses the similarities between myotonic dystrophy and aging, highlighting the role of cellular senescence in its pathophysiology, and reports no new clinical findings; the authors note potential anti-aging therapy applications.
      Myotonic Dystrophy Type 1: Enhancing Patient Management Through Genetic and Multisystem Studies

      research Myotonic dystrophy type 1

      January 2023
      In this thesis, researchers explored ways to enhance the management of myotonic dystrophy type 1 by investigating the genetic inheritance patterns, especially small-sized repeat expansions, and assessing cardiac care, energy expenditure, and body composition in affected individuals.
      Cutaneous Neoplasms in Myotonic Dystrophy Type 1

      research Cutaneous Neoplasms in Myotonic Dystrophy Type 1

      10 citations , January 2016 in “Dermatology”
      This study found that patients with myotonic dystrophy type 1 developed basal cell carcinomas at a younger age than the general population, suggesting a possible predisposition in this group.
      A Failure to Relax: Case of Myotonia in a 31-Year-Old Man

      research A failure to relax.

      October 2007 in “PubMed”
      This case study describes a 31-year-old man with myotonia and a history of hypertrophic cardiomyopathy and androgenic alopecia, who presented with arm and leg weakness.
      Optimal Management of Hair Loss (Alopecia) in Children

      research Optimal Management of Hair Loss (Alopecia) in Children

      49 citations , January 2003 in “American Journal of Clinical Dermatology”
      This review discusses various pediatric hair loss conditions and treatments, highlighting the importance of a holistic approach and noting that no single treatment is universally effective.
      Ptosis in Childhood: Causes, Clinical Presentations, and Management

      research Ptosis in childhood

      15 citations , September 2018 in “Medicine”
      This review discusses the causes and clinical presentations of ptosis in childhood and reports on several observed cases, but provides no new clinical results.
      Atypical Pediatric Presentation of Pilomatricoma

      research Atypical Pediatric Presentation of Pilomatricoma

      3 citations , June 2023 in “Cureus”
      This case study describes a 4-year-old boy whose neck tumor was initially misdiagnosed as scrofuloderma before being correctly identified as a pilomatricoma, underscoring the need to include pilomatricoma in differential diagnoses for persistent skin lesions.
      Pilomatrixoma of the Forearm in an Elderly Male

      research Pilomatrixoma of the Forearm in an Elderly Male

      February 2024 in “Cureus”
      This study presented an elderly male with a nodular lesion diagnosed as pilomatricoma and discussed the value of diagnostic tools like dermoscopy and high-frequency ultrasonography, encouraging clinicians to consider pilomatricoma in differential diagnoses of nodular lesions across all ages.
      Pilomatricoma in the Neck of an Adult Male

      research Pilomatricoma in the neck of an adult male

      January 2022 in “Autopsy and Case Reports”
      This article describes a case of pilomatricoma in a 22-year-old male with successful surgical excision and no recurrence, highlighting its histopathological features and typical clinical presentation.
      Conditions Simulating Androgenetic Alopecia

      research Conditions simulating androgenetic alopecia

      6 citations , January 2015 in “Journal of The European Academy of Dermatology and Venereology”
      This review examines various conditions that resemble androgenetic alopecia, analyzing their pathogenesis and highlighting the difficulties they pose for accurate diagnosis and treatment; it reports no clinical results.
      Androgens and Cardiovascular Disease

      research Androgens and Cardiovascular Disease

      658 citations , June 2003 in “Endocrine reviews”
      This review discusses the role of androgens in the progression of cardiovascular disease and explores novel therapeutic targets without reporting new clinical results.
      Potassium Channel Therapeutics at the Bedside

      research K channel therapeutics at the bedside

      119 citations , June 2005 in “Journal of Molecular and Cellular Cardiology”
      This article reviews the therapeutic potential of potassium channel openers for various conditions related to metabolic distress but does not report new clinical results; it emphasizes the need for further research.